TG Therapeutics Announces Data Presentations at the Upcoming 35th Annual Congress of ECTRIMS 

World News: . []

NEW YORK Aug 29 2019 GLOBE NEWSWIRE -- TG Therapeutics Inc NASDAQ TGTX today LINK  that abstracts featuring ublituximab the LINK  novel glycoengineered anti-CD20 monoclonal antibody in LINK  forms of multiple sclerosis (RMS) h...

More news and information about TG Therapeutics, Inc.

Published By:

Globe Newswire: 12:30 GMT Thursday 29th August 2019

Published: .

Search for other references to "therapeutics" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us